Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2α)

Clinical and Experimental Allergy

Volumn 31, Issue 3, 2001, Pages 387-390

  Dworski, R ^a,b   Jackson Roberts II, L ^a   Murray, J J ^a   Morrow, J D ^a   Hartert, T V ^a   Sheller, J R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

8 iso PGF2a; Allergen; Asthma; Isoprostanes; Oxidant stress; Urinary metabolite

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ALLERGEN; METHACHOLINE; PROSTAGLANDIN DERIVATIVE;

ADULT; ALLERGIC ASTHMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GAS CHROMATOGRAPHY; HUMAN; INHALATION; MASS SPECTROMETRY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN URINE LEVEL; PROVOCATION; URINARY EXCRETION;

ALLERGENS; ASTHMA; DINOPROST; F2-ISOPROSTANES; HUMANS; HYPERSENSITIVITY; OXIDATIVE STRESS;

EID: 0035723661     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2001.01055.x     Document Type: Article

References (10)

1. 2-isoprostanes as an index of oxidative stress in vivo
2. Increased 8-. Isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients
3. Elevated plasma 8-isoprostanes: Marker of asthma severity
4. 2-isoprostanes in atopic asthmatics: Evidence for oxidant stress
5. Urinary prostaglandins. Identification and origin
6. A nomenclature system for the isoprostanes
7. 2a in humans
8. 2a) by a stable isotope dilution mass spectrometric assay
9. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
10. 4 in humans